• Explore /
  • Poster
  • / Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <em>BRAF</em><sup>V600E</sup> metastatic colorectal cancer.

Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAFV600E metastatic colorectal cancer.

Abstract Poster

Authors

null

Van K. Morris II

The University of Texas MD Anderson Cancer Center, Houston, TX

Van K. Morris II, Christine Megerdichian Parseghian , Michelle Escano , Benny Johnson , Kanwal Pratap Singh Raghav , Arvind Dasari , Ryan Huey , Michael J. Overman , Jason Willis , Michael Sangmin Lee , Robert A. Wolff , Bryan K. Kee , John Paul Y.C. Shen , Maria Pia Morelli , Alda Tam , Wai Chin Foo , Lianchun Xiao , Scott Kopetz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04017650

DOI

10.1200/JCO.2022.40.4_suppl.012

Abstract #

12

Poster Bd #

A1

Abstract Disclosures

Similar Posters

First Author: Van K. Morris II

First Author: Scott Kopetz

First Author: Scott Kopetz

First Author: Scott Kopetz